United Therapeutics Corporation Common Stock UTHR
i
Market dataready · fetched 2026-11-04T02:46:15.791Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-04T00:58:58.063118546Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-04T02:46:15.373846+00:00
United Therapeutics Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 654.63 | 39.6% | 9.0% | 558.48 | 48.6% | 9.0% |
| 25Δ | 643.71 | 38.1% | 7.5% | 568.97 | 47.8% | 7.7% |
| 30Δ | 635.51 | 37.7% | 6.4% | 578.29 | 46.9% | 6.6% |
| 35Δ | 628.17 | 37.6% | 5.5% | 586.23 | 47.9% | 5.8% |
| 40Δ | 621.38 | 37.4% | 4.8% | 594.14 | 48.0% | 5.0% |
| 45Δ | 615.01 | 37.5% | 4.2% | 602.16 | 47.1% | 4.3% |
| 50Δ | 608.78 | 37.5% | 3.6% | 609.89 | 47.0% | 3.6% |
| 55Δ | 602.66 | 37.1% | 3.0% | 618.00 | 47.7% | 3.1% |
| 60Δ | 596.58 | 36.7% | 2.6% | 626.24 | 47.8% | 2.6% |
| 65Δ | 590.53 | 36.3% | 2.1% | 635.23 | 48.3% | 2.1% |
| 70Δ | 583.71 | 36.8% | 1.8% | 645.69 | 49.7% | 1.7% |
| 75Δ | 576.96 | 36.6% | 1.4% | 659.48 | 52.7% | 1.4% |
| 80Δ | 570.37 | 35.7% | 1.1% | 679.21 | 57.8% | 1.1% |
20Δ
- Pseudo strike
- 654.63
- IV
- 39.6%
- B/E move
- 9.0%
- Pseudo strike
- 558.48
- IV
- 48.6%
- B/E move
- 9.0%
25Δ
- Pseudo strike
- 643.71
- IV
- 38.1%
- B/E move
- 7.5%
- Pseudo strike
- 568.97
- IV
- 47.8%
- B/E move
- 7.7%
30Δ
- Pseudo strike
- 635.51
- IV
- 37.7%
- B/E move
- 6.4%
- Pseudo strike
- 578.29
- IV
- 46.9%
- B/E move
- 6.6%
35Δ
- Pseudo strike
- 628.17
- IV
- 37.6%
- B/E move
- 5.5%
- Pseudo strike
- 586.23
- IV
- 47.9%
- B/E move
- 5.8%
40Δ
- Pseudo strike
- 621.38
- IV
- 37.4%
- B/E move
- 4.8%
- Pseudo strike
- 594.14
- IV
- 48.0%
- B/E move
- 5.0%
45Δ
- Pseudo strike
- 615.01
- IV
- 37.5%
- B/E move
- 4.2%
- Pseudo strike
- 602.16
- IV
- 47.1%
- B/E move
- 4.3%
50Δ
- Pseudo strike
- 608.78
- IV
- 37.5%
- B/E move
- 3.6%
- Pseudo strike
- 609.89
- IV
- 47.0%
- B/E move
- 3.6%
55Δ
- Pseudo strike
- 602.66
- IV
- 37.1%
- B/E move
- 3.0%
- Pseudo strike
- 618.00
- IV
- 47.7%
- B/E move
- 3.1%
60Δ
- Pseudo strike
- 596.58
- IV
- 36.7%
- B/E move
- 2.6%
- Pseudo strike
- 626.24
- IV
- 47.8%
- B/E move
- 2.6%
65Δ
- Pseudo strike
- 590.53
- IV
- 36.3%
- B/E move
- 2.1%
- Pseudo strike
- 635.23
- IV
- 48.3%
- B/E move
- 2.1%
70Δ
- Pseudo strike
- 583.71
- IV
- 36.8%
- B/E move
- 1.8%
- Pseudo strike
- 645.69
- IV
- 49.7%
- B/E move
- 1.7%
75Δ
- Pseudo strike
- 576.96
- IV
- 36.6%
- B/E move
- 1.4%
- Pseudo strike
- 659.48
- IV
- 52.7%
- B/E move
- 1.4%
80Δ
- Pseudo strike
- 570.37
- IV
- 35.7%
- B/E move
- 1.1%
- Pseudo strike
- 679.21
- IV
- 57.8%
- B/E move
- 1.1%
Options history
Table
| Date | IV (%) |
|---|---|
| 35.24% | |
| 34.24% | |
| 33.45% | |
| 33.42% | |
| 34.32% | |
| 30.72% | |
| 32.40% | |
| 31.28% | |
| 33.84% | |
| 34.06% | |
| 35.67% | |
| 38.51% | |
| 33.33% | |
| 33.55% | |
| 32.89% | |
| 32.83% | |
| 32.51% | |
| 32.98% | |
| 32.65% | |
| 33.03% | |
| 34.15% | |
| 34.72% | |
| 34.28% | |
| 35.59% | |
| 34.62% | |
| 35.56% | |
| 33.12% | |
| 36.08% | |
| 37.49% | |
| 37.96% | |
| 38.42% | |
| 33.59% | |
| 32.22% | |
| 32.99% | |
| 32.21% | |
| 33.75% | |
| 33.60% | |
| 33.57% | |
| 33.02% | |
| 34.16% | |
| 34.01% | |
| 33.39% | |
| 33.64% | |
| 33.89% | |
| 35.80% | |
| 37.12% | |
| 34.66% | |
| 35.79% | |
| 36.73% | |
| 37.02% | |
| 37.67% | |
| 34.90% | |
| 33.80% | |
| 33.74% | |
| 32.94% | |
| 34.32% | |
| 34.96% | |
| 34.84% | |
| 34.97% | |
| 34.41% | |
| 33.00% | |
| 35.67% |
Drug Manufacturers - Specialty & Generic
VTRS
Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
More →XERS
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in…
More →ZTS
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
More →ACB
Description unavailable
More →AKBA
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease. The company is…
More →ALKS
Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in…
More →